- 12% off
- 12% off
S23 is a selective androgen receptor modulator (SARM) that has been the subject of research for its potential applications in muscle development, fat loss, and other related areas. Its selective binding to androgen receptors in targeted tissues offers a unique profile that has attracted attention within the scientific community.
While S23 has shown promise in pre-clinical studies and early-phase research, it is important to acknowledge that the existing literature is limited, and further investigations are needed to fully understand its long-term effects, safety profile, and specific mechanisms of action.
Researchers working with S23 should adhere to proper laboratory safety protocols and ethical guidelines.
Check out our SARMs PAGE for more great products
S23 is gaining significant attention within the scientific community for its potential to define physique, promote lean muscle mass gains, and increase fat loss. It has also been compared to anabolic steroids due to its efficiency in binding to androgen receptors.
S23 is known as one of the most potent Selective Androgen Receptor Modulators available. Researchers have noted similarities to anabolic steroids in terms of lean muscle mass gains and fat loss, while also observing minimal water retention.
Research on nonhuman subjects has shown 100% infertility achievable with small doses, with quick reversibility upon discontinuation.
Though designed to minimize traditional anabolic-androgenic steroids' side effects, caution with higher doses and longer cycles is advised. A post-cycle therapy (PCT) program with Tamoxifen and Clomiphene may be necessary.
With promising attributes such as harder lean muscle, increased endurance, and 96% bioavailability, S23 is emerging as a leading health and fitness research product. Its ban in professional sports reflects its performance-enhancing capacities.
Female Researchers Speak Out: Accumulating data and recent reports conclude that S23 may be associated with enhanced libido in women. The findings, though preliminary, open up new avenues for research and understanding of this powerful SARM. Continued investigation is required to understand the full implications and safety of these effects.
IUPAC name: (2S)-N-(4-cyano-3-trifluoromethylphenyl)-3-(3-fluoro-4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide CAS Number: 1010396-29-8
Molar mass: 416.76 g·mol−1
S23 is intended for research purposes only. It is not approved for human consumption or therapeutic use.